Utility of Lp-PLA2 in Lipid-Lowering Therapy

Simvastatin Reduces Expression and Activity of Lipoprotein-Associated Phospholipase A2 in the Aorta of Hypercholesterolaemic Atherosclerotic Rabbits

(2013) Z Qiao et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Lipoprotein-Associated Phospholipase A2 Activity and Incident Coronary Heart Disease Among Men and Women With Type 2 Diabetes

(2010) I. J. Hatoum et al.   DIABETES

Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome

(2010) Ping Fan et al.   HUMAN REPRODUCTION

Effect of Statins on the Viability of Macrophages and Smooth Muscle Cells

(2010) Valerie Croons et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Profiling of phospholipids in lipoproteins by multiplexed hollow fiber flow field-flow fractionation and nanoflow liquid chromatography–tandem mass spectrometry

(2010) Ju Yong Lee et al.   JOURNAL OF CHROMATOGRAPHY A

The role of phospholipid transfer protein in lipoprotein-mediated neutralization of the procoagulant effect of anionic liposomes

(2010) C. OSLAKOVIC et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Humoral Mechanisms of Atherogenesis

(2009) Joana R. Batuca et al.   Annals of the New York Academy of Sciences

Increased PAFAH and Oxidized Lipids Are Associated With Inflammation and Atherosclerosis in Hypercholesterolemic Pigs

(2009) Dieuwke De Keyzer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lipoprotein-Associated Phospholipase A 2 and Risk of Congestive Heart Failure in Older Adults

(2009) Takeki Suzuki et al.   Circulation-Heart Failure

The evaluation of IL-12 concentration, PAF-AH, and PLA2 activity in patients with type 1 diabetes treated with intensive insulin therapy

(2009) Małgorzata Wegner et al.   CLINICAL BIOCHEMISTRY

Lipoprotein-associated phospholipase A2 and atherosclerosis

(2009) Robert L Wilensky et al.   CURRENT OPINION IN LIPIDOLOGY

Phospholipase A2 inhibitors

(2009) Hector M Garcia-Garcia et al.   CURRENT OPINION IN LIPIDOLOGY

Phospholipase A2 inhibitors in the treatment of atherosclerosis: a new approach moves forward in the clinic

(2009) Keith E Suckling   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Altered distribution of plasma platelet-activating factor acetylhydrolase between high-density lipoprotein and low-density lipoprotein in patients with polycystic ovary syndrome

(2009) Ping Fan et al.   FERTILITY AND STERILITY

Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines

(2008) Michael H. Davidson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Coronary Artery Disease Events in Primary and Secondary Prevention

(2008) Jeffrey L. Anderson   AMERICAN JOURNAL OF CARDIOLOGY

Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A2 as a Cardiovascular Risk Marker

(2008) Marshall A. Corson et al.   AMERICAN JOURNAL OF CARDIOLOGY

Lipoprotein-Associated and Secretory Phospholipase A2 in Cardiovascular Disease: The Epidemiological Evidence

(2008) Wolfgang Koenig et al.   CARDIOVASCULAR DRUGS AND THERAPY

Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque

(2008) Patrick W. Serruys et al.   CIRCULATION

Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol

(2008) Emile R. Mohler et al.   CYTOMETRY PART A

The effect of marine n-3 fatty acids in different doses on plasma concentrations of Lp-PLA2 in healthy adults

(2008) Maria Weinkouff Pedersen et al.   EUROPEAN JOURNAL OF NUTRITION

Lipoprotein-Associated Phospholipase A2 Predicts Progression of Cardiac Allograft Vasculopathy and Increased Risk of Cardiovascular Events in Heart Transplant Patients

(2008) Eugenia Raichlin et al.   TRANSPLANTATION

Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes

(2006) Athanasios I. Papathanasiou et al.   ATHEROSCLEROSIS

Lipoprotein-associated phospholipase A2 concentrations in plasma are associated with the extent of coronary artery disease and correlate to adipose tissue levels of marine n-3 fatty acids

(2006) Erik Berg Schmidt et al.   ATHEROSCLEROSIS